Understanding How the New U.S. Patent Laws Affect Business Strategy for Emerging Pharmaceutical, Biotechnology, and Medical Device Companies
With the “America Invents Act” and new U.S. patent laws now in effect or being implemented over the next year, emerging pharmaceutical, biotechnology, and medical devices companies are asking what are the implications of the changes and how do we adapt?
During the seminar, attendees will gain insight on building a business and patent portfolio strategy that responds to the new first-to-file patent system. Additionally, attendees will learn about the potential advantages under the new patent laws with regard to maintaining certain information as trade secrets.
Wednesday, May 16, 2012 at the North Carolina Biotechnology Center, RTP.
For further information and registration, please click here.